The management of retinopathy of prematurity

Paediatric Drugs

Volumn 3, Issue 4, 2001, Pages 263-272

  Reynolds, J D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOGENESIS INHIBITOR; INOSITOL; VASCULOTROPIN;

BLINDNESS; CRYOTHERAPY; HUMAN; HYPEROXIA; HYPOXIA; LASER COAGULATION; NEWBORN INTENSIVE CARE; NEWBORN SCREENING; OXYGEN THERAPY; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RETINA DETACHMENT SURGERY; RETROLENTAL FIBROPLASIA; REVIEW; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; VITRECTOMY;

EID: 0035038608     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200103040-00003     Document Type: Review

References (50)

1. Retinopathy of prematurity in middle-income countries
2. Multicenter trial of cryotherapy for retinopathy of prematurity: Preliminary results
3. Visual acuity in infants after vitrectomy for severe retinopathy of prematurity
4. Visual acuity of eyes after vitrectomy for retinopathy of prematurity: Follow-up at 5 1/2 years
5. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia
6. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
7. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity
8. Vascular development in primate retina: Comparison of laminar plexus formation in monkey and human
9. Factors controlling ocular angiogenesis
10. Development of the subretinal space in the preterm human eye: Ultrastructural and immunocytochemical studies
11. Vitamin E and retrolental fibroplasia: Ultrastructural mechanism of clinical efficacy
12. A controlled clinical trial of light and retinopathy of prematurity
13. Lack of efficacy of light reduction in preventing retinopathy of prematurity
14. Incidence and early course of retinopathy of prematurity
15. 2 variation determines the severity of oxygen-induced retinopathy in newborn rats
16. New developments in neonatology: Less severe retinopathy of prematurity?
17. The decreasing incidence and severity of retinopathy of prematurity
18. Decreased prevalence of retinopathy of prematurity in an inner-city hospital
19. Retinopathy of prematurity in infants less than 29 weeks gestation: 3 1/2 years pre- and postsurfactant
20. Retinopathy of prematurity in a Danish county: Trends over the 12-year period 1982-93
21. Incidence and severity of retinopathy of prematurity
22. Multicenter trial of cryotherapy for retinopathy of prematurity: Three month outcome
23. The design of the multicenter study of light reduction in retinopathy of prematurity (LIGHT-ROP)
24. Childhood blindness
25. Relationship between serum inositol concentration and development of retinopathy of prematurity: A prospective study
26. Retrolental fibroplasia: Efficacy of vitamin E in a double-blind clinical study of preterm infants
27. Influence on retrolental fibroplasia of intramuscular vitamin E administration during respiratory distress syndrome
28. Vitamin E and retinopathy of prematurity: Follow-up at one year
29. Tocopherol efficacy and safety for preventing retinopathy of prematurity: A randomized, controlled, double-masked trial
30. Retinopathy of prematurity: Etiology
31. Effect of bright light in the hospital nursery on the incidence of retinopathy of prematurity
32. Retrolental fibroplasia and light
33. Retrolental fibroplasia: The negative role of light, mydriatics, and the ophthalmoscopic examination in its etiology
34. Reduced incidental light exposure: Effect on the development of retinopathy of prematurity in low birth weight infants
35. Ophthalmic care of very low birth weight infants, report 4: Clinical studies on the influence of light on the incidence of retinopathy of prematurity
36. Inositol supplementation in premature infants with respiratory distress syndrome
37. Postnatal inositol levels in preterm infants
38. Multicenter trial of cryotherapy for retinopathy of prematurity: Snellen visual acuity and structural outcome at 5 1/2 years after randomization
39. Histopathology and vascular endothelial growth factor in untreated and diode lasertreated retinopathy of prematurity
40. A comparison of cryotherapy versus diode laser retinopexy in 100 consecutive infants treated for threshold retinopathy of prematurity
41. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity
42. Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity
43. Diode laser ablation for threshold retinopathy of prematurity: Short-term structural outcome
44. Cataracts associated with treatment for retinopathy of prematurity
45. Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity
46. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial, I: Primary outcomes
47. On 'supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial, I: Primary outcomes'
48. Fibroblastic overgrowth of persistent tunica vasculosa lentis in premature infants. II: Report of cases: Clinical aspects
49. Studies on the effect of high oxygen administration in retrolental fibroplasia
50. Retrolental fibroplasia: Cooperative study of retrolental fibroplasia and the use of oxygen